跳至主要内容
临床试验/NCT03860831
NCT03860831Unknown1 期

Lecturer of Anesthesia ,Intensive Care and Pain Management in Faculty of Medicine Ain Shams University

Ain Shams University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年3月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
40
试验地点
2
主要终点
change in sedation level after intranasal or intramuscular ketamine midazolam mixture administration.

研究概览

简要总结

Ketamine and Midazolam are well known sedative drugs that can be given through different routes such as intravenous, intramuscular, oral, rectal and intranasal route. Anesthetic staff usually prefer intravenous route but sometimes inserting venous access is difficult in uncooperative mentally disabled children. Intranasal ketamine+Midazolam can be a needless effective alternative in these vulnerable patients

详细描述

Sedation and analgesia decreases the need for general anesthesia outside the operating room. Intravenous route is the standard way of sedation, but its use can be limited in uncooperative mentally disabled children. Active Physical restraint of children causes emotional trauma for both parents and children particularly in these patients. Oral sedation has multiple disadvantages as delayed onset of action, better taste, the need of different types of syrup or honey according to the preference of the patient, children may refuse to take oral drugs or even spit it and it also causes postoperative nausea and vomiting. In contrast, intramuscular sedation is an easy effective way of administration and it is preferred due to its rapid onset of action and higher predictability of the duration, however, fear of the pain of injections is considered a disadvantage in this vulnerable pediatric patients. nasal route is an important alternative route because it is a painless and needless approach with rapid drug absorption from nasal mucosa reaching the cerebrospinal fluid and bypassing the first pass metabolism in the liver. Intranasal midazolam for sedation of children was first described by Wilton et al .Recently studies proved the use of nasal ketamine spray for treatment of resistant depression in adults. Ketamine as a premedication in children has been also successfully given through the nasal route. In Ain shams University hospitals we give either oral Midazolam or intramuscular Ketamine followed by sevoflurane or propofol for pediatric procedural sedation. Nasal Midazolam or Ketamine has not been tried despite being a feasible choice with many possible advantages. Combination of ketamine and midazolam causes deeper sedation and less dysphoric reaction of ketamine so in this study, we evaluate the efficacy and safety of administration of this combination through intranasal route for procedural sedation in children with mental developmental delay outside the operating room.

After approval from our Ethical Committee, written informed consent from the parents will be taken. Forty children presented with autism,mongolism or cerebral palsy classified as American Society of Anesthesiologists (ASA) physical status I and II, aged between 4 and 12 years will be enrolled in our study, and computer-generated assignment will be used for randomization and to allocate patients to one of two equal study groups.

patients will fulfill the fasting hours if elective while the patients in ER will be asked to wait for six hours after last meal.

Patients will be divided into two groups Group IN:will receive intranasal ketamine 5 mg/kg and midazolam 0.2 mg/kg, and we will give intranasal sedatives by using mucosal atomisation device.

Group IM:will receive intramuscular ketamine 5 mg/kg, and midazolam 0.2 mg/kg Sedation levels after 10, 20, and 30 min will be evaluated by Pediatric Sedation State Scale (PSSS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

surgeon who are providing medical procedure and nurse who records vital data and level of sedation

入排标准

年龄范围
4 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria of the patients were:
  • Mentally affected children (autism,down syndrome and cerebral palsy)
  • children who are scheduled for Short procedures (30 minutes or less) under sedation

排除标准

  • parents refusal.
  • child cooperation and acceptance of venipuncture or cannula in situ.
  • children with known allergy to ketamine or midazolam.
  • liver or renal organ dysfunction.
  • suspected difficult cannulation.
  • congenital heart disease.
  • active pulmonary infection or asthma.
  • increased intracranial tension or intraocular pressure.
  • severe trauma0
  • significant nasal discharge or obstruction.

研究组 & 干预措施

intranasal (IN)

Experimental

Group IN will receive nasal ketamine+midazolam mixture by mucosal atomisation device: midazolam (0.2 mg/kg) +ketamine (5mg/kg).

the calculated dose will be equally divided into the two nostrils by the parents

干预措施: Ketamine + midazolam (Drug)

intramuscular (IM)

Active Comparator

Group IM will receive intramuscular administration of liquid ketamine +midazolam mixture:midazolam (0.2 mg/kg) +ketamine (5mg/kg) in the gluteal region.

Mild to moderate restraint was done with the help of the parents during drug administration.

干预措施: Ketamine + midazolam (Drug)

结局指标

主要结局

change in sedation level after intranasal or intramuscular ketamine midazolam mixture administration.

时间窗: every 10 minutes through the study till one hour after administration

sedation level measured by Pediatric Sedation State Scale (PSSS): State 5: Movement impedes procedure and requires forceful immobilization State 4: Movement requires gentle immobilization for positioning State 3: Facial expression of pain or anxiety State 2: Quiet, not moving, no frown, no verbalization of complaint (ideal state) State 1: Deeply asleep with normal vital signs, but requires airway intervention or assistance (e.g., central or obstructive apnea) State 0: Deeply asleep with abnormal physiologic parameters that require acute intervention (e.g., O2 saturation \<90%, hypotension, bradycardia) highest score is 0 and least score is 5

次要结局

  • parents satisfaction(two hours after administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanaa Farag Mahmoud Wasfy

lecturer of aneathesia

Ain Shams University

研究点 (2)

Loading locations...

相似试验